DERBY MEDICAL CENTRE — All Prescriptions & Medications — Page 3
Practice Code: H81051 | EPSOM, KT19 8AG
Showing results 101-150 of 593
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 377 | 220.9K | £2.6K | +42.9% ▲ | |
| Memantine hydrochloride | 375 | 16.5K | £3.4K | +13.5% ▲ |
| Fluticasone furoate | 366 | 504 | £3.2K | +88.9% ▲ |
| Hydroxocobalamin | 363 | 401 | £888 | -24.6% ▼ |
| Atenolol | 359 | 28.1K | £638 | -40.5% ▼ |
| Trimethoprim | 359 | 12.3K | £605 | +75.7% ▲ |
| Estradiol with progestogen | 348 | 18.7K | £11.7K | +2.1% ▲ |
| 347 | 3,545 | £1.5K | +39.1% ▲ | |
| Lactulose | 342 | 178.1K | £1.7K | +3.9% ▲ |
| Felodipine | 342 | 18.6K | £3.0K | -42.4% ▼ |
| Clarithromycin | 342 | 7,354 | £1.6K | +39.4% ▲ |
| Olanzapine | 339 | 8,899 | £866 | -8.5% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 338 | 40.8K | £1.9K | +88.1% ▲ |
| Methotrexate | 335 | 8,258 | £5.8K | +2.9% ▲ |
| Sodium valproate | 330 | 52.0K | £4.8K | +3.8% ▲ |
| Letrozole | 322 | 17.5K | £1.5K | +72.4% ▲ |
| Esomeprazole | 313 | 18.5K | £1.0K | -22.6% ▼ |
| Donepezil hydrochloride | 308 | 11.5K | £1.5K | -0.2% vs avg |
| Tiotropium bromide | 304 | 9,361 | £13.8K | +0.0% vs avg |
| Buprenorphine | 303 | 1,222 | £5.0K | -17.3% ▼ |
| 302 | 56.0K | £1.9K | -36.3% ▼ | |
| Carbamazepine | 293 | 44.5K | £2.6K | -1.3% vs avg |
| Lidocaine hydrochloride | 292 | 2,714 | £2.3K | +69.3% ▲ |
| Gabapentin | 291 | 31.7K | £988 | -70.9% ▼ |
| Mirabegron | 287 | 12.2K | £11.2K | -28.6% ▼ |
| Ferrous fumarate | 282 | 29.2K | £1.2K | -61.1% ▼ |
| 282 | 46.1K | £2.0K | +588.8% ▲ | |
| Insulin glargine | 281 | 1,608 | £14.6K | -1.0% vs avg |
| Eplerenone | 280 | 10.0K | £1.2K | +5.6% ▲ |
| Levetiracetam | 277 | 26.3K | £5.9K | -39.5% ▼ |
| Risperidone | 274 | 10.8K | £969 | +8.3% ▲ |
| Dexamethasone | 274 | 1,485 | £926 | +59.4% ▲ |
| Mesalazine (Systemic) | 266 | 43.7K | £21.3K | +11.0% ▲ |
| Mebeverine hydrochloride | 263 | 25.4K | £784 | -15.3% ▼ |
| Rivaroxaban | 261 | 12.2K | £8.1K | -57.3% ▼ |
| Estradiol | 260 | 6,898 | £3.4K | -3.6% ▼ |
| Duloxetine hydrochloride | 251 | 12.5K | £1.1K | -60.5% ▼ |
| Cefalexin | 234 | 6,777 | £667 | +101.2% ▲ |
| Bimatoprost | 234 | 8,250 | £4.2K | +57.4% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 232 | 7,207 | £752 | +51.9% ▲ |
| Linagliptin | 232 | 12.4K | £14.0K | -43.4% ▼ |
| Aciclovir | 230 | 14.3K | £646 | +54.6% ▲ |
| Pantoprazole | 229 | 11.3K | £525 | -16.7% ▼ |
| Morphine sulfate | 229 | 51.3K | £1.4K | -65.1% ▼ |
| Diltiazem hydrochloride | 224 | 14.5K | £2.4K | -27.1% ▼ |
| Clobetasone butyrate | 224 | 12.0K | £1.9K | +9.7% ▲ |
| Azithromycin | 223 | 4,677 | £1.2K | +75.9% ▲ |
| Lisinopril | 222 | 12.8K | £288 | -79.7% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 222 | 38.1K | £2.2K | -1.8% vs avg |
| Solifenacin | 215 | 9,821 | £446 | -54.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.